ADDISON ZAYA: Open Payments
NPI 1669953972 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 26 payments from 10 companies in 2025. Trend: 2023 $1,200 · 2024 $820 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $183 |
| Supernus Pharmaceuticals, Inc. | 6 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $90 |
| ABBVIE INC. | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| Lundbeck LLC | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Itamar Medical Inc | 1 | $31 |
| Corium, LLC | 1 | $26 |
Products named: REXULTI, Qelbree, CAPLYTA, VRAYLAR, FANAPT, SPRAVATO, TRINTELLIX, WatchPATONE.
Industry payments across TX — which companies pay providers there.
